This October, Satyabrata Sinha, Ph.D., joined Cleveland Cord Blood Center’s research staff to lead CCBC’s continued exploration of cord-blood derived stem cell therapy for the treatment of Parkinson’s disease.

Sinha has a strong research background with a Ph.D. focused on cancer biology. His postdoctoral work in the field of ophthalmology is related to age-related macular degeneration and other retinal degenerative diseases.

Most recently, Sinha has been a Visiting Research Specialist at the University of Illinois Chicago. Prior to this, he conducted research as a postdoctoral fellow at the Cleveland Clinic, Case Western Reserve University, West Virginia University Eye Institute and Sanford Burnham Prebys Medical Discovery Institute in San Diego.

We’re pleased to welcome Satyabrata Sinha to our research team.